当前位置: »论坛 › 科研专区 › 文献互助› Treatment With Ensifentrine, a Dual PDE3 and PDE4 In ...

[ATS] Treatment With Ensifentrine, a Dual PDE3 and PDE4 Inhibitor, Significantly Reduced Exacerbation Rate and Risk in Subjects With COPD: Sub-group Results From the Phase 3 Trial, Enhance-2

求助已关闭

ZoeA 发表于 2026-4-27 16:05:58 | 显示全部楼层 |阅读模式

悬赏10积分

期刊：C40. CLINICAL TRIALS AND NOVEL INTERVENTIONS IN COPD

文献作者：A. Anzueto; T. Rheault; T. Bengtsson; K. Rickard

出版日期：2023-5-

DOI号：10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4998

文献链接：https://doi.org/10.1164/ajrccm-c ... tingabstracts.a4998

当前文献来源于 American Thoracic Society。

备注信息：

使用道具捐赠获取积分应助有误反馈